<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MEDRXIV</journal-id>
<journal-title-group>
<journal-title>medRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">medRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/2021.02.17.21251556</article-id>
<article-version>1.3</article-version>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Infectious Diseases (except HIV/AIDS)</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Salivary detection of COVID-19. Clinical performance of oral sponge sampling for SARS-CoV-2 testing</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0846-9941</contrib-id>
<name><surname>Marquette</surname><given-names>Charles Hugo</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6468-1648</contrib-id>
<name><surname>Boutros</surname><given-names>Jacques</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1899-9612</contrib-id>
<name><surname>Benzaquen</surname><given-names>Jonathan</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2014-1236</contrib-id>
<name><surname>Ili&#x00E9;</surname><given-names>Marius</given-names></name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Labaky</surname><given-names>Mickelina</given-names></name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Benchetrit</surname><given-names>Didier</given-names></name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lavrut</surname><given-names>Thibaut</given-names></name>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3465-8180</contrib-id>
<name><surname>Leroy</surname><given-names>Sylvie</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chemla</surname><given-names>Richard</given-names></name>
<xref ref-type="aff" rid="a7">7</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5485-1511</contrib-id>
<name><surname>Carles</surname><given-names>Michel</given-names></name>
<xref ref-type="aff" rid="a8">8</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tanga</surname><given-names>Virginie</given-names></name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Maniel</surname><given-names>Charlotte</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Bordone</surname><given-names>Olivier</given-names></name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>All&#x00E9;gra</surname><given-names>Maryline</given-names></name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lespinet</surname><given-names>Virginie</given-names></name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Fayada</surname><given-names>Julien</given-names></name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Griffonnet</surname><given-names>Jennifer</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hofman</surname><given-names>V&#x00E9;ronique</given-names></name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0431-9353</contrib-id>
<name><surname>Hofman</surname><given-names>Paul</given-names></name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Universit&#x00E9; C&#x00F4;te d&#x2019;Azur, Centre Hospitalier Universitaire de Nice, FHU OncoAge, Department of Pulmonary Medicine and Thoracic Oncology</institution>, Nice, <country>France</country></aff>
<aff id="a2"><label>2</label><institution>Universit&#x00E9; C&#x00F4;te d&#x2019;Azur, CNRS, INSERM, Institute of Research on Cancer and Aging (IR- CAN)</institution>, Nice, <country>France</country></aff>
<aff id="a3"><label>3</label><institution>Universit&#x00E9; C&#x00F4;te d&#x2019;Azur, FHU OncoAge, Centre Hospitalier Universitaire de Nice, Laboratory of Clinical and Experimental Pathology, Biobank (BB-0033-00025)</institution>, Nice, <country>France</country></aff>
<aff id="a4"><label>4</label><institution>SYNLAB Barla, 41 boulevard Louis Braille</institution>, Nice, <country>France</country></aff>
<aff id="a5"><label>5</label><institution>Universit&#x00E9; C&#x00F4;te d&#x2019;Azur, Centre Hospitalier Universitaire de Nice, Laboratoire de Virologie</institution>, CHU de Nice, Nice, <country>France</country></aff>
<aff id="a6"><label>6</label><institution>CNRS UMR 7275 - Institut de Pharmacologie Mol&#x00E9;culaire et Cellulaire - Universit&#x00E9; C&#x00F4;te d&#x2019;Azur</institution>, Nice, <country>France</country></aff>
<aff id="a7"><label>7</label><institution>Ville de Nice</institution>, Nice, <country>France</country></aff>
<aff id="a8"><label>8</label><institution>Universit&#x00E9; C&#x00F4;te d&#x2019;Azur, Centre Hospitalier Universitaire de Nice, Department of Infectious Diseases</institution>, Nice, <country>France</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label><bold>Corresponding author:</bold> Dept of Pulmonary Medicine and Thoracic Oncology, H&#x00F4;pital Pasteur, 30 av de la voie romaine, 06001 Nice, France (<email>marquette.c@chu-nice.fr</email>)</corresp>
</author-notes>
<pub-date pub-type="epub">
<year>2021</year>
</pub-date>
<elocation-id>2021.02.17.21251556</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>2</month>
<year>2021</year>
</date>
<date date-type="rev-recd">
<day>10</day>
<month>5</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>5</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2021</copyright-year>
<license><license-p>The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.</license-p></license>
</permissions>
<self-uri xlink:href="21251556.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>ABSTRACT</title>
<sec>
<title>Background</title>
<p>The current diagnostic standard for coronavirus 2019 disease (COVID-19) is reverse transcriptase-polymerase chain reaction (RT-PCR) testing with naso-pharyngeal (NP) swabs. The invasiveness and need for trained personnel make the NP technique unsuited for repeated community-based mass screening. We developed a technique to collect saliva in a simple and easy way with the sponges that are usually used for tamponade of epistaxis. This study was carried out to validate the clinical performance of oral sponge (OS) sampling for SARS-CoV-2 testing.</p></sec>
<sec>
<title>Methods</title>
<p>Over a period of 22 weeks, we collected prospectively 409 paired NP and OS samples from consecutive subjects presenting to a public community-based free screening center. Subjects were referred by their attending physician because of recent COVID-19 symptoms (n=147) or by the contact tracing staff of the French public health insurance since they were considered as close contacts of a laboratory-confirmed COVID-19 case (n=262).</p></sec>
<sec>
<title>Results</title>
<p>In symptomatic subjects, RT-PCR SARS-CoV-2 testing with OS showed a 96.5% (95%CI: 89.6-94.8) concordance with NP testing, and, a 93.3% [95%CI: 89.1-97.3] sensitivity. In close contacts the NP-OS concordance (93.8% [95%CI: 90.9-96.7]) and OS sensitivity (71.9% [95%CI: 66.5-77.3]) were slightly lower.</p></sec>
<sec>
<title>Conclusion</title>
<p>These results strongly suggest that OS testing is a straightforward, low-cost and high-throughput sampling method that can be used for frequent RT-PCR testing of COVID-19 patients and mass screening of populations.</p></sec>
<sec>
<title>Summary of the &#x201C;take home&#x201D; message</title>
<p>OS sampling for SARS-CoV2 RT-PCR is an easy to perform, straightforward self-administered sampling technique, which has a sensitivity of up to 93.3% in symptomatic patients and 71% in close contact subjects.</p></sec>
</abstract>
<counts>
<page-count count="23"/>
</counts>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>Paul Hofman is a member of the scientific advisory board (group of european experts) of Biocartis.  However, this boad is totally independ of Biocartis</p></notes>
<notes notes-type="clinical-trial-statement">
<title>Clinical Trial</title><p>NCT04418206</p></notes>
<notes notes-type="financial-disclosure">
<title>Funding Statement</title><p>This work was supported by Conseil Departemental 06, Ville de Nice, Metropole Nice Cote d'Azur, Fonds de Dotation AVENI, and from private donators.
Acknowledgements:
Special thanks to E. Faidhi, N. Fridlyand, A. Rauscher, E. Maris, the Lauro family and to the many private donators for their generous contribution.
</p></notes>
<notes notes-type="disclosures">
<title>Author Declarations</title><p>I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.</p><p>Yes</p><p>The details of the IRB/oversight body that provided approval or exemption for the research described are given below:</p><p>The promoter of the study was the Center Hospitalier Universitaire de Nice. The agreement for the study of the Institutional review board Sud Mediterranee V was obtained on April 22, 2020 (registration # 20.04014.35208). SHAM liability insurance (n 159087). </p><p>All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.</p><p>Yes</p><p>I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).</p><p>Yes</p><p> I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.</p><p>Yes</p></notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>the legend in Table 1 contained errors that have been corrected in this version</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>I<sc>ntroduction</sc></title>
<p>To date, reverse transcriptase-polymerase chain reaction (RT-PCR) testing of naso-pharyn-geal swab specimens (NP) is the gold standard for diagnosis of coronavirus 2019 disease (COVID-19) [<xref ref-type="bibr" rid="c1">1</xref>&#x2013;<xref ref-type="bibr" rid="c4">4</xref>]. While its specificity is 100%, its sensitivity is 80-90% during the first 10 days of the disease of a COVID-19 positive subject [<xref ref-type="bibr" rid="c5">5</xref>, <xref ref-type="bibr" rid="c6">6</xref>] and depends on the operator and on the moment the sampling is performed during the course of the infection. RT-PCR on NP, known as being of &#x201C;high analytical sensitivity", is particularly well suited for symptomatic patients. However, in the context of a pandemic, when mass screening or repeated testing is required, the use of NP for RT-PCR is not appropriate [<xref ref-type="bibr" rid="c7">7</xref>] since its acceptability is debated and its implementation requires time and dedicated trained staff.</p>
<p>Antigen-detecting rapid diagnostic tests (Ag-RDT) are quick, simple, inexpensive and allow the decentralization of testing of symptomatic people at the point of care. As for a conventional RT-PCR test, they are performed with NP and thus need to be done by a trained operator [<xref ref-type="bibr" rid="c8">8</xref>]. The sensitivity varies considerably (60 to 95%) [<xref ref-type="bibr" rid="c8">8</xref>&#x2013;<xref ref-type="bibr" rid="c10">10</xref>] and the invasiveness makes Ag-RDT poorly suited for repeated testing or mass screening.</p>
<p>Sampling of saliva offers a promising alternative to NP [<xref ref-type="bibr" rid="c11">11</xref>]. Various pathophysiological pathways explain the presence of the SARS-CoV-2 in saliva of patients with COVID-19 [<xref ref-type="bibr" rid="c12">12</xref>&#x2013;<xref ref-type="bibr" rid="c17">17</xref>]. Tests with saliva involve amplification of viral RNA by RT-PCR or by Reverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP). These tests are non-invasive, easily re-peatable and can be performed with or even without assistance, leading in the latter case to a lower risk of contamination of nursing staff. RT-PCR on saliva samples has been approved in Japan since June 2020 and in the USA since October 2020. Following the publication of an umbrella review [<xref ref-type="bibr" rid="c18">18</xref>] including ten meta-analyses [<xref ref-type="bibr" rid="c11">11</xref>, <xref ref-type="bibr" rid="c19">19</xref>&#x2013;<xref ref-type="bibr" rid="c27">27</xref>] as well as trials meeting prede-fined quality criteria, the French &#x201C;Haute Autorit&#x00E9; de Sant&#x00E9;&#x201D; [<xref ref-type="bibr" rid="c28">28</xref>] retained very recently the indication of RT-PCR on saliva in the following three situations: 1 / on symptomatic patients as a second-line alternative to NP when NP is difficult or impossible (deviation of the nasal septum, very young patients, patients with psychiatric disorders, etc.); 2 / on contact persons as a second-line alternative to NP for whom NP is difficult or impossible; 3 / in the first instance as part of targeted mass screening, particularly if it is repeated regularly such as in schools, universities, for staff in health care establishments, in nursing homes, etc &#x2026; From a practical point of view, saliva sampling should be performed more than 30 minutes after the last drink, food, cigarette/e-cigarette, tooth brushing or mouth rinsing [<xref ref-type="bibr" rid="c28">28</xref>]. Saliva spit in a dry and sterile bottle is preferred; otherwise, saliva is collected using a dedicated system. Based on our research on the respiratory epithelium and on COVID-19 [<xref ref-type="bibr" rid="c29">29</xref>&#x2013;<xref ref-type="bibr" rid="c33">33</xref>] we aimed to investigate the potential use of the RT-PCR detection of SARS-COV-2 on oral sponge samples (OS) as an alternative to NP for symptomatic subjects and close contacts.</p>
</sec>
<sec id="s2">
<title>M<sc>ethods</sc></title>
<sec id="s2a">
<title>Study design and participants</title>
<p>The present study was conducted on a prospective cohort of consecutive volunteers at the Nice-C&#x00F4;te d&#x2019;Azur Metropolis community-based COVID-19 center (Nice, France), accessible for free screening to the general population.</p>
<p>During the first part of the study (Sept 21, 2020 to Jan 6, 2021) we enrolled subjects referred by their attending physician because of recent (&#x2264; 2 weeks) symptoms of COVID-19 [<xref ref-type="bibr" rid="c34">34</xref>]. During the second part of the study (Feb 6 to March 8, 2021) we enrolled subjects referred by the contact tracing staff of the French public health insurance [<xref ref-type="bibr" rid="c35">35</xref>], since they were considered as close contacts of a laboratory-confirmed COVID-19 case (<xref rid="fig1" ref-type="fig">figure 1</xref>).</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1:</label>
<caption><p>Trial profile</p></caption>
<graphic xlink:href="21251556v3_fig1.tif"/>
</fig>
</sec>
<sec id="s2b">
<title>Procedures</title>
<sec id="s2b1">
<title>Specimen Collection</title>
<p>After signing an informed consent to participate, all volunteers were interviewed and underwent paired sampling: NP and OS in a random order. Disposable NP nylon swabs (type A-04. Jiangsu Han-Heng Medical technology Co., Ltd. Changzou, Jiangsu, China) were eluted into a vial containing viral transport medium (<xref ref-type="app" rid="app1">appendix 1</xref>) and transported within 4 hours to the Synlab Barla laboratory (Nice, France). Small hydroxylated polyvinyl acetate (PVA) sponges (Merocel&#x00AE; Standard Dressing, r&#x00E9;f 400400, Medtronic), usually used for tamponade of epistaxis, were placed in the mouth by the subjects themselves and taken out after one minute and inserted into a sterile collection tube transported within 4 hours to the Idylla platform (Biocartis, Mechelen, Belgium) of the Laboratory of Clinical and Experimental Pathology (LPCE), (H&#x00F4;pital Pasteur 1, Nice). No instructions were given regarding the need to fast, to have chewed gum or smoked a cigarette/e-cigarette.</p>
</sec>
<sec id="s2b2">
<title>Detection of SARS-CoV-2 RNA on NP samples</title>
<p>The Synlab Barla laboratory is a private biological analysis laboratory that is under contract with the Nice-C&#x00F4;te d&#x2019;Azur Metropolis for COVID screening tests. This laboratory used RT-PCR to detect SARS-CoV-2 RNA on NP during the first part of the study. For logistical reasons, this laboratory switched to the Transcription Mediated Amplification (TMA) technique to detect SARS-CoV-2 RNA during the second part of the study. According to the guidelines of the French society for Microbiology [<xref ref-type="bibr" rid="c36">36</xref>] for RT-PCR, the result was considered positive when the Ct (cycle threshold) value for the N and/or on Orf1b genes was equal or less than 36. For TMA the result was considered as positive when the RLU was above 850.</p>
</sec>
<sec id="s2b3">
<title>Analysis of OS samples</title>
<p>We described previously RT-PCR for detection of SARS-CoV-2 RNA on the Idylla platform and showed a 100% positive and negative agreement between this technique and standard-of-care RT-PCR tests [<xref ref-type="bibr" rid="c33">33</xref>]. Upon arrival of the sample, 200&#x03BC;l of the OS eluate were pipetted with a sterile tip (D. Dutscher, reference 134000), placed individually into Idylla SARS-CoV-2 test cartridges (Biocartis, reference A1043/6) and underwent fully automated nucleic acid testing including extraction, amplification, and detection in a single-use cartridge. The duration of the run took 90 minutes (&#x002B;/-10 min). The residual volume OS eluate was immediately aliquoted and stored at &#x2212;80&#x00B0;C in the Nice COVID-19 Biobank, which is S96-900 certified by AFNOR [<xref ref-type="bibr" rid="c30">30</xref>]. According to the manufacturer, the Idylla SARS-CoV-2 test provides a qualitative result for the presence or absence of SARS-CoV-2 RNA with a corresponding quality status. The Biocartis SARS-CoV-2 test included 2 genes (N, Orf1b) covered by 5 PCR targets (2 N targets and 3 Orf1b targets). A positive result required at least 2 amplified N targets [by setting a quantification cycle (Cq) of 41.9] and/or at least one or more amplified Orf1b targets. As Orf1b is highly specific no threshold was required for this gene.</p>
</sec>
<sec id="s2b4">
<title>External validation</title>
<p>All OS eluates were sent to the Synlab Barla laboratory and underwent RT-PCR using the ORF1ab and N genes Da An Gene DA0992-Detection Kit for 2019-nCoV (Da An Gene Co., Ltd. Sun Yat-sen University, Guangzhou, Guangdong, China). During the first part of the study this external validation was performed on the OS eluates stored at &#x2212;80&#x00B0;C in the Nice COVID-19 biobank) [<xref ref-type="bibr" rid="c30">30</xref>]. During the second part of the study, external validation was carried out in the Synlab Barla laboratory on fresh samples transferred from the Nice COVID-19 biobank.</p>
<p>The different analyses were processed in a double-blind way: the results of the reference standard test were unavailable to the readers of the index test and vice versa.</p>
</sec>
</sec>
<sec id="s2c">
<title>Outcomes</title>
<p>The primary outcome was the clinical performance of OS compared to NP for SARS- CoV-2 screening in symptomatic and close contact subjects. For each group (symptomatic vs close contacts) we extracted the number of individuals positive for SARS- CoV-2 in both NP and OS (a), those positive only with NP (b), those positive only with OS (c) and (d) those negative with both NO and OS (<xref rid="tbl1a" ref-type="table">Table 1</xref>). From these data, we calculated the concordance of the two types of sample (a&#x002B;d)/(a&#x002B;b&#x002B;c&#x002B;d). We also calculated the sensitivity of the test on each type of sample. The estimation of the sensitivity of a test requires a reference diagnosis. Since NP sampling has been shown to produce false negatives by RT-PCR, sensitivities for NP and OS are defined here respectively as (a&#x002B;b)/(a&#x002B;b&#x002B;c) and (a&#x002B;c)/(a&#x002B;b&#x002B;c), considering as a true positive any individual with a positive result on one or the other sample. This definition of a positive individual is in agreement with the US-CDC and the ECDC directives on SARS-CoV-2 testing [<xref ref-type="bibr" rid="c37">37</xref>, <xref ref-type="bibr" rid="c38">38</xref>].</p>
<table-wrap id="tbl1a" orientation="portrait" position="float">
<label>Table 1a:</label>
<caption><p>Clinical performance of oral sponge (OS) compared to nasopharyngeal swab (NP) for SARS- CoV-2 screening. LPCE, Idylla platform.</p></caption>
<graphic xlink:href="21251556v3_tbl1a.tif"/>
</table-wrap>
<table-wrap id="tbl1b" orientation="portrait" position="float">
<label>Table 1b:</label>
<caption><p>Clinical performance of oral sponge (OS) compared to nasopharyngeal swab (NP) for SARS- CoV-2 screening. External validation at the Synlab Barla laboratory platform</p></caption>
<graphic xlink:href="21251556v3_tbl1b.tif"/>
</table-wrap>
<p>Secondary outcomes included the description of the studied population and the comparison between Ct values measured with NP and OS, an approximate proxy of viral loads. To calculate the sample size in the absence of data regarding the sensitivity of OS in symptomatic subjects, we calculated the sensitivity of OS once the first 40 paired (NP/OS) samples were obtained. This sensitivity was 85%. Given this estimate and a desired lower bound of the 95% confidence interval for sensitivity of at least 80%, 144 volunteers were needed to complete the study in symptomatic subjects. To deal with the dropout risk we decided to include 149 volunteers.</p>
</sec>
<sec id="s2d">
<title>Statistics</title>
<p>Continuous variables are presented as means (&#x00B1; SD), and categorical variables as numbers and percentages. Baseline characteristics between patients with and without COVID-19 were compared using the Student&#x2019;s t-test or Wilcoxon - Mann Whitney for quantitative variables based on the normality of the distribution of parameters or using the Chi-Square test for qualitative variables.</p>
</sec>
<sec id="s2e">
<title>Ethics and regulatory authorizations</title>
<p>The promoter of the study was the Center Hospitalier Universitaire de Nice. The agreement for the study of the Institutional review board Sud M&#x00E9;diterran&#x00E9;e V was obtained on April 22, 2020 (registration # 20.04014.35208). SHAM liability insurance (n&#x00B0; 159087). The study is registered in <ext-link ext-link-type="uri" xlink:href="http://ClinicalTrial.gov">ClinicalTrial.gov</ext-link> (NCT04418206).</p>
</sec>
<sec id="s2f">
<title>Role of the funding sources</title>
<p>The organizations that supported this study played no role in its design, patient selection, data collection, analysis or interpretation, report writing, or decision to submit the document for publication. Authors had full access to all data and responsibility of submission for publication.</p>
</sec>
</sec>
<sec id="s3">
<title>R<sc>esults</sc></title>
<p>Four hundred and eleven subjects underwent COVID-19 diagnostic testing over the 22 weeks of the study, 149 during the first part of the study conducted on symptomatic subjects and 262 during the second part of the study conducted on close contacts. Two symptomatic subjects declined to perform NP once OS had been performed and were excluded from subsequent analyses. One had a positive OS RT-PCR, and the other was negative. The study therefore covers the remaining 409 participants (<xref rid="fig1" ref-type="fig">figure 1</xref>).</p>
<p>The 147 symptomatic subjects were predominantly women 86/147 (58.5%). Their mean age was 40 &#x00B1; 15 years. The interval between symptom onset and testing was 3.6 &#x00B1; 2.6 days and most participants (107/147 [72.8%]) were sampled at the early stage of the disease, i.e., within 4 days of symptom onset. Of these symptomatic subjects, 59 (40.1%) had a positive RT-PCR result with one or both of the sampling techniques and were thus diagnosed COVID-19. No clinical symptoms distinguished between RT-PCR positive and negative subjects (<xref rid="fig2" ref-type="fig">figure 2</xref>), with the exception of anosmia and dysgeusia, which were more frequent in RT-PCR positive subjects (42% vs. 10%, p &#x003C;0.001 and 38 vs. 16%, p = 0.004) and sore throat, which was significantly more common in RT-PCR negative subjects (36 vs. 10%, p = 0.001).</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2:</label>
<caption><p>Self-reported symptoms (%)</p></caption>
<graphic xlink:href="21251556v3_fig2.tif"/>
</fig>
<fig id="fig3" position="float" fig-type="figure">
<label>Figure 3:</label>
<caption><p>Viral load of NP and OS as indirectly assessed by the Ct for the Orf1b and N genes</p></caption>
<graphic xlink:href="21251556v3_fig3.tif"/>
</fig>
<p>For these symptomatic subjects, the Ct values for the Orf 1b and N genes with OS showed a more than 3-point increase compared with NP; the magnitude of this difference indicates a more than 10-fold lower quantity of viral genetic material in OS samples [<xref ref-type="bibr" rid="c39">39</xref>].</p>
<p>The 262 close contacts with a laboratory-confirmed COVID-19 case were predominantly women 145/262 (55.3%). The mean age was 41 &#x00B1; 15 years. The contact was identified in the household (n=41; 15.6%), in the family (n=56; 21.4%); in the close environment (n=40; 15.3%), at work (n=65; 24.8%), or was not known by the subject (n=60; 22.9%). Of these close contact subjects, 57 (21.7%) had a positive RT-PCR result with one or both of the sampling techniques. Differences in viral load between the NP and the OS could not be assessed in close contact subjects since viral RNA detection with NP relied on TMA and not on RT-PCR in this part of the study.</p>
<p>In the symptomatic subjects, the NP-OS concordance was 96.5% (95%CI: 93.5 &#x2013; 99.5) and the OS sensitivity was 93.2% (95%CI: 89.1 &#x2013; 97.3) with the Idylla platform. With the Synlab Barla platform, the NP-OS concordance was 89.0% (95%CI: 83.9 &#x2013; 94.1) and the OS sensitivity was 76.3% (95%CI: 69.4 &#x2013; 83.2) (<xref rid="tbl1a" ref-type="table">table 1</xref>).</p>
<p>In the close contact subjects, the NP-OS concordance was 93.8% (95%CI: 90.9 &#x2013; 96.7) and the OS sensitivity was 71.9% (95%CI: 66.5 &#x2013; 77.3) with the Idylla platform. With the Synlab barla platform, the NP-OS concordance was 94.2% (95%CI: 91.4 &#x2013; 97.0) and the OS sensitivity was 73.7% (95%CI: 68.4 &#x2013; 79.0) (<xref rid="tbl1a" ref-type="table">table 1</xref>).</p>
</sec>
<sec id="s4">
<title>D<sc>iscussion</sc></title>
<p>In this study, RT-PCR SARS-CoV-2 testing with OS showed a high level of concordance (with NP testing), 96.5% (95%CI: 89.6-94.8) and sensitivity, 93.3 (95%CI: 89.1-97.3) for symptomatic subjects and a slightly lower level of concordance, 93.8% (95%CI: 90.9-96.7) and sensitivity, 71.9% (95%CI: 66.5-77.3) in close contacts of a laboratory-confirmed COVID-19 case. These results obtained in ambulatory subjects presenting to a public community-based screening center, strongly suggest that OS, a straightforward, low-cost and high-throughput sampling material can be used for frequent RT-PCR testing of COVID-19 patients and mass screening of populations.</p>
<p>During the early phase of the COVID-19 pandemic, many molecular tests, immunoassays and sampling methods were rapidly developed and validated using archived biological samples of known virological status, albeit many still await clinical validation [<xref ref-type="bibr" rid="c40">40</xref>]. To evaluate the clinical performance of OS, compared to NP, the present study was carried out according to the standards recommended by the French &#x201C;Haute Autorit&#x00E9; de Sant&#x00E9;&#x201D; [<xref ref-type="bibr" rid="c8">8</xref>]; i.e., a prospective comparative clinical study relating to a series of individuals of unknown COVID-19 status, recruited consecutively; a salivary test including at least two molecular targets; and by the US and European CDC directives; i.e. definition of a positive individual when comparing two diagnostic SARS-Cov-2 testing methods [<xref ref-type="bibr" rid="c37">37</xref>,<xref ref-type="bibr" rid="c38">38</xref>].</p>
<p>In published studies that compared salivary and NP testing, symptomatic subjects were the dominant inclusion profile (85%), especially in the majority of short series of hospitalized patients [<xref ref-type="bibr" rid="c18">18</xref>]. Only 6 cohorts of equal or larger size than ours reported comparative test results obtained in a community-based settings [<xref ref-type="bibr" rid="c41">41</xref>&#x2013;<xref ref-type="bibr" rid="c46">46</xref>].</p>
<p>Given the particularly high incidence of COVID-19 in the Nice metropolitan area throughout our study period (incidence between 330 and 720/100,000), our rate of positivity (21-41%) was higher than the rates observed in these 6 cohorts (1.5% to 10.7%). Despite this difference, our NP-OS concordance and the sensitivity of RT-PCR on NP and on OS are in agreement with the results reported for these cohorts; and with the notion of no association between salivary and NP test performance and viral prevalence [<xref ref-type="bibr" rid="c19">19</xref>].</p>
<p>RT-PCR with OS performed at the Synlab Barla platform showed a significantly lower sensitivity than Idylla platform in symptomatic subjects. This discrepancy may be due to 2 factors: the Idylla platform uses 3 Orf1 and 2 N targets while the Synlab Barla platform uses only one Orf1 and one N target; preservation at &#x2212;80&#x00B0;C for several weeks may have altered the nucleic acids. The discrepancy disappeared in the second part of the study in which the external validation of OS testing at the Synlab Barla platform was done on fresh samples in real time.</p>
<p>The significant difference in viral load observed between samples of nasopharyngeal and buccal origin may be due to several parameters, notably endogenous to the laboratory [(i.e. total volume of sample collection buffer/medium, sample preparation method (heat, lysis methods)] and laboratory reagent volumes used in each step of the RT-PCR process. A similar difference has been observed by others [<xref ref-type="bibr" rid="c2">2</xref>, <xref ref-type="bibr" rid="c47">47</xref>&#x2013;<xref ref-type="bibr" rid="c49">49</xref>] and explains why the diagnostic yield of NP is considered to be higher than that of throat swabs [<xref ref-type="bibr" rid="c48">48</xref>, <xref ref-type="bibr" rid="c49">49</xref>]. Thus, this difference most likely has a pathophysiological basis, related to the fact that the mouth squamous cells act as a viral reservoir to a lesser degree than the nasopharynx ciliated cells [<xref ref-type="bibr" rid="c31">31</xref>, <xref ref-type="bibr" rid="c32">32</xref>, <xref ref-type="bibr" rid="c50">50</xref>]. As a consequence, the interpretative cut-offs for NP Ct [<xref ref-type="bibr" rid="c36">36</xref>] hardly apply to saliva samples.</p>
<p>The OS sampling method is well standardized. It does not need sialagogic drugs, nor clearing the throat or spitting effort, nor particular constraints such as early morning saliva sampling before tooth brushing and breakfast, avoiding eating, drinking, gum chewing, smoking, or vaping. [<xref ref-type="bibr" rid="c51">51</xref>&#x2013;<xref ref-type="bibr" rid="c53">53</xref>]. It does not need dedicated trained nursing staff and its acceptability makes it possible to consider repeating the test even in institutionalized elderly people or in children.</p>
<p>The question as to whether the 72% sensitivity we observed in contact subjects is good enough to identify SARS-CoV-2 infected people in the setting of mass screening has been debated by Mina et al. in a landmark position paper [<xref ref-type="bibr" rid="c7">7</xref>]. In this paper they distinguished between a low frequency tests with a high analytical sensitivity and high frequency tests with low analytical sensitivity. RT-PCR with NP samples belongs to the former category and is well suited to diagnosis of COVID-19 in symptomatic subjects. Whereas the OS sampling method described herein belongs to the latter category and would be more effective in identifying, isolating, and thus filtering out currently infected persons, including those who are asymptomatic.</p>
<p>We industrialized the OS process in the form of an &#x201C;all-in-one&#x201D; kit simplifying extraction of the biological liquid (<xref rid="fig4" ref-type="fig">figure 4</xref>) and presently intend to clinically validate the performance of this sampling method with the pooling technique [<xref ref-type="bibr" rid="c54">54</xref>] for mass screening.</p>
<fig id="fig4" position="float" fig-type="figure">
<label>Figure 4:</label>
<caption><p>All-in-on saliva sampling technique with a PVA sponge and a flexible, double-capped plastic tube.</p></caption>
<graphic xlink:href="21251556v3_fig4.tif"/>
</fig>
</sec>
</body>
<back>
<sec sec-type="data-availability">
<title>Data Availability</title>
<p>all data referred to in this manuscript can be available after contacting the corresponding author</p>
</sec>
<sec id="s5">
<title>Funding</title>
<p>This work was supported by Conseil D&#x00E9;partemental 06, Ville de Nice, M&#x00E9;tropole Nice C&#x00F4;te d&#x2019;Azur, Fonds de Dotation AVENI, and from private donators.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>Special thanks to E. Faidhi, N. Fridlyand, A. Rauscher, E. Maris, the Lauro family and to the many private donators for their generous contribution.</p>
</ack>
<ref-list>
<title>R<sc>eferences</sc></title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Hanson</surname> <given-names>KE</given-names></string-name>, <string-name><surname>Caliendo</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Arias</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Englund</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Patel</surname> <given-names>R</given-names></string-name>, <string-name><surname>Alayli</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Kalot</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Falck-Ytter</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Morgan</surname> <given-names>RL</given-names></string-name>, <string-name><surname>Murad</surname> <given-names>MH</given-names></string-name>, <string-name><surname>Sultan</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bhimraj</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mustafa</surname> <given-names>RA</given-names></string-name>. <source>Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19</source>. : <volume>72</volume>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Zou</surname> <given-names>L</given-names></string-name>, <string-name><surname>Ruan</surname> <given-names>F</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>M</given-names></string-name>, <string-name><surname>Liang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Hong</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kang</surname> <given-names>M</given-names></string-name>, <string-name><surname>Song</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Xia</surname> <given-names>J</given-names></string-name>, <string-name><surname>Guo</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Song</surname> <given-names>T</given-names></string-name>, <string-name><surname>He</surname> <given-names>J</given-names></string-name>, <string-name><surname>Yen</surname> <given-names>H-L</given-names></string-name>, <string-name><surname>Peiris</surname> <given-names>M</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>J.</given-names></string-name> <article-title>SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients</article-title>. <source>New England Journal of Medicine Massachusetts Medical Society</source>; <year>2020</year>; <volume>382</volume>: <fpage>1177</fpage>&#x2013;<lpage>1179</lpage>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Sullivan</surname> <given-names>PS</given-names></string-name>, <string-name><surname>Sailey</surname> <given-names>C</given-names></string-name>, <string-name><surname>Guest</surname> <given-names>JL</given-names></string-name>, <string-name><surname>Guarner</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kelley</surname> <given-names>C</given-names></string-name>, <string-name><surname>Siegler</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Valentine-Graves</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gravens</surname> <given-names>L</given-names></string-name>, <string-name><surname>Del Rio</surname> <given-names>C</given-names></string-name>, <string-name><surname>Sanchez</surname> <given-names>TH</given-names></string-name>. <article-title>Detection of SARS-CoV-2 RNA and Antibodies in Diverse Samples: Protocol to Validate the Sufficiency of Provider-Observed, Home-Collected Blood, Saliva, and Oropharyngeal Samples</article-title>. <source>JMIR Public Health Surveill</source> <year>2020</year>; <volume>6</volume>: <fpage>e19054</fpage>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Pondaven-Letourmy</surname> <given-names>S</given-names></string-name>, <string-name><surname>Alvin</surname> <given-names>F</given-names></string-name>, <string-name><surname>Boumghit</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Simon</surname> <given-names>F.</given-names></string-name> <article-title>How to perform a nasopharyngeal swab in adults and children in the COVID-19 era</article-title>. <source>Eur Ann Otorhinolaryngol Head Neck Dis</source> <year>2020</year>; <volume>137</volume>: <fpage>325</fpage>&#x2013;<lpage>327</lpage>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Kucirka</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Lauer</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Laeyendecker</surname> <given-names>O</given-names></string-name>, <string-name><surname>Boon</surname> <given-names>D</given-names></string-name>, <string-name><surname>Lessler</surname> <given-names>J.</given-names></string-name> <article-title>Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction&#x2013;Based SARS-CoV-2 Tests by Time Since Exposure</article-title>. <source>Ann Intern Med American College of Physicians</source>; <year>2020</year>; <volume>173</volume>: <fpage>262</fpage>&#x2013;<lpage>267</lpage>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Arevalo-Rodriguez</surname> <given-names>I</given-names></string-name>, <string-name><surname>Buitrago-Garcia</surname> <given-names>D</given-names></string-name>, <string-name><surname>Simancas-Racines</surname> <given-names>D</given-names></string-name>, <string-name><surname>Zambrano-Achig</surname> <given-names>P</given-names></string-name>, <string-name><surname>Campo</surname> <given-names>RD</given-names></string-name>, <string-name><surname>Ciapponi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sued</surname> <given-names>O</given-names></string-name>, <string-name><surname>Martinez-Garc&#x00ED;a</surname> <given-names>L</given-names></string-name>, <string-name><surname>Rutjes</surname> <given-names>AW</given-names></string-name>, <string-name><surname>Low</surname> <given-names>N</given-names></string-name>, <string-name><surname>Bossuyt</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Perez-Molina</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Zamora</surname> <given-names>J.</given-names></string-name> <article-title>False-negative results of initial RT-PCR assays for COVID-19: A systematic review</article-title>. <source>PLOS ONE Public Library of Science</source>; <year>2020</year>; <volume>15</volume>: <fpage>e0242958</fpage>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Mina</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Parker</surname> <given-names>R</given-names></string-name>, <string-name><surname>Larremore</surname> <given-names>DB</given-names></string-name>. <article-title>Rethinking Covid-19 Test Sensitivity &#x2014; A Strategy for Containment</article-title>. <source>New England Journal of Medicine Massachusetts Medical Society</source>; <year>2020</year>; <volume>383</volume>: <fpage>e120</fpage>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="website"><collab>Haute Autorit&#x00E9; de Sant&#x00E9;</collab>. <source>Revue rapide sur les tests de d&#x00E9;tection antig&#x00E9;nique du virus SARS-CoV-2. 8 octobre 2020</source> (<ext-link ext-link-type="uri" xlink:href="https://www.has-sante.fr/upload/docs/application/pdf/2020-10/synthese_tests_antigeniques_vd.pdf">https://www.has-sante.fr/upload/docs/application/pdf/2020-10/synthese_tests_antigeniques_vd.pdf</ext-link>).</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="website"><collab>World Health Organization</collab>. (<year>2020</year>). <source>Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays: interim guidance, 11 September 2020. World Health Organization</source>. <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/handle/10665/334253">https://apps.who.int/iris/handle/10665/334253</ext-link>. License: CC BY-NC-SA 3.0 IGO [Internet]. [cited 2021 Jan 22]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications-detail-redirect/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays">https://www.who.int/publications-detail-redirect/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays</ext-link>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="website"><collab>&#x00C9;valuation de la performance diagnostique de neuf tests rapides antig&#x00E9;niques COVID-19</collab> [Internet]. [cited 2021 Jan 22].Available from: <ext-link ext-link-type="uri" xlink:href="https://www.aphp.fr/contenu/evaluation-de-la-performance-diagnostique-de-neuf-tests-rapides-antigeniques-covid-19">https://www.aphp.fr/contenu/evaluation-de-la-performance-diagnostique-de-neuf-tests-rapides-antigeniques-covid-19</ext-link>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Butler-Laporte</surname> <given-names>G</given-names></string-name>, <string-name><surname>Lawandi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Schiller</surname> <given-names>I</given-names></string-name>, <string-name><surname>Yao</surname> <given-names>M</given-names></string-name>, <string-name><surname>Dendukuri</surname> <given-names>N</given-names></string-name>, <string-name><surname>McDonald</surname> <given-names>EG</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>TC</given-names></string-name>. <article-title>Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis</article-title>. <source>JAMA Intern Med</source> <year>2021</year>; <volume>181</volume>: <fpage>353</fpage>&#x2013;<lpage>360</lpage>.</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="book"><string-name><given-names>To</given-names> <surname>KK-W</surname></string-name>, <string-name><surname>Tsang</surname> <given-names>OT-Y</given-names></string-name>, <string-name><surname>Leung</surname> <given-names>W-S</given-names></string-name>, <string-name><surname>Tam</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>T-C</given-names></string-name>, <string-name><surname>Lung</surname> <given-names>DC</given-names></string-name>, <string-name><surname>Yip</surname> <given-names>CC-Y</given-names></string-name>, <string-name><surname>Cai</surname> <given-names>J-P</given-names></string-name>, <string-name><surname>Chan</surname> <given-names>JM-C</given-names></string-name>, <string-name><given-names>Chik</given-names> <surname>TS-H</surname></string-name>, <string-name><given-names>Lau</given-names> <surname>DP-L</surname></string-name>, <string-name><given-names>Choi</given-names> <surname>CY-C</surname></string-name>, <string-name><surname>Chen</surname> <given-names>L-L</given-names></string-name>, <string-name><surname>Chan</surname> <given-names>W-M</given-names></string-name>, <string-name><surname>Chan</surname> <given-names>K-H</given-names></string-name>, <string-name><surname>Ip</surname> <given-names>JD</given-names></string-name>, <string-name><given-names>Ng</given-names> <surname>AC-K</surname></string-name>, <string-name><surname>Poon</surname> <given-names>RW-S</given-names></string-name>, <string-name><surname>Luo</surname> <given-names>C-T</given-names></string-name>, <string-name><surname>Cheng</surname> <given-names>VC-C</given-names></string-name>, <string-name><given-names>Chan</given-names> <surname>JF-W</surname></string-name>, <string-name><surname>Hung</surname> <given-names>IF-N</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>H</given-names></string-name>, <string-name><surname>Yuen</surname> <given-names>K-Y.</given-names></string-name> <chapter-title>Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study</chapter-title>. <source>The Lancet Infectious Diseases</source> <publisher-name>Elsevier</publisher-name>; <year>2020</year>; <volume>20</volume>: <fpage>565</fpage>&#x2013;<lpage>574</lpage>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Wei</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Alvarez</surname> <given-names>X</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Du</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>H</given-names></string-name>, <string-name><surname>Jiang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lam</surname> <given-names>P</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Lackner</surname> <given-names>A</given-names></string-name>, <string-name><surname>Qin</surname> <given-names>C</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>Z.</given-names></string-name> <article-title>Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques</article-title>. <source>J Virol</source> <year>2011</year>; <volume>85</volume>: <fpage>4025</fpage>&#x2013;<lpage>4030</lpage>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Lu</surname> <given-names>B</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Li</surname> <given-names>B</given-names></string-name>, <string-name><surname>Zheng</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>J</given-names></string-name>, <string-name><surname>Hu</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>H.</given-names></string-name> <article-title>Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice</article-title>. <source>Immunology</source> <year>2010</year>; <volume>130</volume>: <fpage>254</fpage>&#x2013;<lpage>261</lpage>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Silva-Boghossian</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Colombo</surname> <given-names>APV</given-names></string-name>, <string-name><surname>Tanaka</surname> <given-names>M</given-names></string-name>, <string-name><surname>Rayo</surname> <given-names>C</given-names></string-name>, <string-name><surname>Xiao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Siqueira</surname> <given-names>WL</given-names></string-name>. <article-title>Quantitative Proteomic Analysis of Gingival Crevicular Fluid in Different Periodontal Conditions</article-title>. <source>PLOS ONE Public Library of Science</source>; <year>2013</year>; <volume>8</volume>: <fpage>e75898</fpage>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Xu</surname> <given-names>H</given-names></string-name>, <string-name><surname>Zhong</surname> <given-names>L</given-names></string-name>, <string-name><surname>Deng</surname> <given-names>J</given-names></string-name>, <string-name><surname>Peng</surname> <given-names>J</given-names></string-name>, <string-name><surname>Dan</surname> <given-names>H</given-names></string-name>, <string-name><surname>Zeng</surname> <given-names>X</given-names></string-name>, <string-name><surname>Li</surname> <given-names>T</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>Q.</given-names></string-name> <article-title>High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa</article-title>. <source>International Journal of Oral Science Nature Publishing Group</source>; <year>2020</year>; <volume>12</volume>: <fpage>1</fpage>&#x2013;<lpage>5</lpage>.</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Dawes</surname> <given-names>C</given-names></string-name>, <string-name><surname>Wong</surname> <given-names>DTW</given-names></string-name>. <article-title>Role of Saliva and Salivary Diagnostics in the Advancement of Oral Health</article-title>. <source>J Dent Res SAGE Publications Inc</source>; <year>2019</year>; <volume>98</volume>: <fpage>133</fpage>&#x2013;<lpage>141</lpage>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="website"><string-name><surname>Haute Autorit&#x00E9; de</surname> <given-names>Sant&#x00E9;.</given-names></string-name> <source>M&#x00E9;ta-analyse de l&#x2019;int&#x00E9;r&#x00EA;t diagnostique des tests RT-PCR salivaires de d&#x00E9;tection du SARS-CoV-2</source>. <ext-link ext-link-type="uri" xlink:href="https://www.has-sante.fr/jcms/p_3237008/fr/meta-analyse-de-l-interet-diagnostique-des-tests-rt-pcr-salivaires-de-detection-du-sars-cov-2">https://www.has-sante.fr/jcms/p_3237008/fr/meta-analyse-de-l-interet-diagnostique-des-tests-rt-pcr-salivaires-de-detection-du-sars-cov-2</ext-link> (accessed <date-in-citation content-type="access-date">Apr. 10, 2021</date-in-citation>)]</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="other"><string-name><surname>Ibrahimi</surname> <given-names>N</given-names></string-name>, <string-name><surname>Delaunay-Moisan</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hill</surname> <given-names>C</given-names></string-name>, <string-name><surname>Teuff</surname> <given-names>GL</given-names></string-name>, <string-name><surname>Rupprecht</surname> <given-names>J-F</given-names></string-name>, <string-name><surname>Thuret</surname> <given-names>J-Y</given-names></string-name>, <string-name><surname>Chaltiel</surname> <given-names>D</given-names></string-name>, <string-name><surname>Potier</surname> <given-names>M-C.</given-names></string-name> <article-title>Screening for SARS-CoV-2 by RT-PCR: saliva or nasopharyngeal swab? Systematic review and meta-analysis</article-title>. <source>medRxiv Cold Spring Harbor Laboratory Press</source>; <year>2021</year>; : 2021.02.10.21251508.</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Moreira</surname> <given-names>VM</given-names></string-name>, <string-name><surname>Mascarenhas</surname> <given-names>P</given-names></string-name>, <string-name><surname>Machado</surname> <given-names>V</given-names></string-name>, <string-name><surname>Botelho</surname> <given-names>J</given-names></string-name>, <string-name><surname>Mendes</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Taveira</surname> <given-names>N</given-names></string-name>, <string-name><surname>Almeida</surname> <given-names>MG</given-names></string-name>. <article-title>Diagnosis of SARS-Cov-2 Infection by RT-PCR Using Specimens Other Than Naso-and Oropharyngeal Swabs: A Systematic Review and Meta-Analysis</article-title>. <source>Diagnostics Multidisciplinary Digital Publishing Institute</source>; <year>2021</year>; <volume>11</volume>: <fpage>363</fpage>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="other"><string-name><surname>Bastos</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Perlman-Arrow</surname> <given-names>S</given-names></string-name>, <string-name><surname>Menzies</surname> <given-names>D</given-names></string-name>, <string-name><surname>Campbell</surname> <given-names>JR</given-names></string-name>. <article-title>The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs?: A Systematic Review and Meta-analysis</article-title>. <source>Ann Intern Med</source> <year>2021</year>;.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="other"><string-name><surname>Lee</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Herigon</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Benedetti</surname> <given-names>A</given-names></string-name>, <string-name><surname>Pollock</surname> <given-names>NR</given-names></string-name>, <string-name><surname>Denkinger</surname> <given-names>CM</given-names></string-name>. <article-title>Performance of Saliva, Oropharyngeal Swabs, and Nasal Swabs for SARS-CoV-2 Molecular Detection: A Systematic Review and Meta-analysis</article-title>. <source>J Clin Microbiol</source> <year>2021</year>;.</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Kivel&#x00E4;</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Jarva</surname> <given-names>H</given-names></string-name>, <string-name><surname>Lappalainen</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kurkela</surname> <given-names>S.</given-names></string-name> <article-title>Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis</article-title>. <source>J Med Virol</source> <year>2021</year>; <volume>93</volume>: <fpage>1256</fpage>&#x2013;<lpage>1258</lpage>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="other"><string-name><surname>Meng</surname> <given-names>M</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>X</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Zou</surname> <given-names>J.</given-names></string-name> <article-title>The positive rate of saliva for the detection of 2019-nCoV and possible factors related to the sensitivity results</article-title>. <source>J Med Virol</source> <year>2020</year>;.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="other"><string-name><surname>Peeters</surname> <given-names>E</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>SKDA</given-names></string-name>, <string-name><surname>Vandesompele</surname> <given-names>J</given-names></string-name>, <string-name><surname>Mestdagh</surname> <given-names>P</given-names></string-name>, <string-name><surname>Hutse</surname> <given-names>V</given-names></string-name>, <string-name><surname>Arbyn</surname> <given-names>M.</given-names></string-name> <article-title>Rapid systematic review of the sensitivity of SARS-CoV-2 molecular testing on saliva compared to nasopharyngeal swabs</article-title>. <source>medRxiv Cold Spring Harbor Laboratory Press</source>; <year>2020</year>; : 2020.08.05.20168716.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Ricc&#x00F2;</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ranzieri</surname> <given-names>S</given-names></string-name>, <string-name><surname>Peruzzi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Valente</surname> <given-names>M</given-names></string-name>, <string-name><surname>Marchesi</surname> <given-names>F</given-names></string-name>, <string-name><surname>Balzarini</surname> <given-names>F</given-names></string-name>, <string-name><surname>Bragazzi</surname> <given-names>NL</given-names></string-name>, <string-name><surname>Signorelli</surname> <given-names>C.</given-names></string-name> <source>RT-qPCR assays based on saliva rather than on nasopharyngeal swabs are possible but should be interpreted with caution: results from a systematic review and meta-analysis.: Acta Bio Med</source> <year>2020</year>; <volume>91</volume>: <fpage>e2020025</fpage>&#x2013;<lpage>e2020025</lpage>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="other"><string-name><surname>Czumbel</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Kiss</surname> <given-names>S</given-names></string-name>, <string-name><surname>Farkas</surname> <given-names>N</given-names></string-name>, <string-name><surname>Mandel</surname> <given-names>I</given-names></string-name>, <string-name><surname>Hegyi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Nagy</surname> <given-names>&#x00C1;</given-names></string-name>, <string-name><surname>Szak&#x00E1;cs</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Hegyi</surname> <given-names>P</given-names></string-name>, <string-name><surname>Steward</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Varga</surname> <given-names>G.</given-names></string-name> <article-title>Saliva as a Candidate for COVID-19 Diagnostic Testing: A Meta-Analysis</article-title>. <source>Front Med (Lausanne)</source> <year>2020</year>; : <fpage>465</fpage>&#x2013;<lpage>465</lpage>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="website"><collab>Avis n&#x00B0; 2021.0007/AC/SEAP du 10 f&#x00E9;vrier 2021 du coll&#x00E8;ge de la HAS relatif aux modifications des conditions d&#x2019;inscription sur la LAP mentionn&#x00E9;e &#x00E0; l&#x2019;article L. 162-1-7 du CSS, &#x00E0; la d&#x00E9;tection du g&#x00E9;nome du virus SARS-CoV-2 par technique de transcription inverse suivie d&#x2019;une amplification (RT-PCR) sur pr&#x00E9;l&#x00E8;vement salivaire [Internet]. Haute Autorit&#x00E9; de Sant&#x00E9;</collab> [cited 2021 Apr 7].Available from: <ext-link ext-link-type="uri" xlink:href="https://www.has-sante.fr/jcms/p_3236975/fr/avis-n-2021-0007/ac/seap-du-10-fevrier-2021-du-college-de-la-has-relatif-aux-modifications-des-conditions-d-inscription-sur-la-lap-mentionnee-a-l-article-l-162-1-7-du-css-a-la-detection-du-genome-du-virus-sars-cov-2-par-technique-de-transcription-inverse-suivie-d-une-amplification-rt-pcr-sur-prelevement-salivaire">https://www.has-sante.fr/jcms/p_3236975/fr/avis-n-2021-0007/ac/seap-du-10-fevrier-2021-du-college-de-la-has-relatif-aux-modifications-des-conditions-d-inscription-sur-la-lap-mentionnee-a-l-article-l-162-1-7-du-css-a-la-detection-du-genome-du-virus-sars-cov-2-par-technique-de-transcription-inverse-suivie-d-une-amplification-rt-pcr-sur-prelevement-salivaire</ext-link>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Deprez</surname> <given-names>M</given-names></string-name>, <string-name><surname>Zaragosi</surname> <given-names>L-E</given-names></string-name>, <string-name><surname>Truchi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Becavin</surname> <given-names>C</given-names></string-name>, <string-name><surname>Ruiz Garc&#x00ED;a</surname> <given-names>S</given-names></string-name>, <string-name><surname>Arguel</surname> <given-names>M-J</given-names></string-name>, <string-name><surname>Plaisant</surname> <given-names>M</given-names></string-name>, <string-name><surname>Magnone</surname> <given-names>V</given-names></string-name>, <string-name><surname>Lebrigand</surname> <given-names>K</given-names></string-name>, <string-name><surname>Abelanet</surname> <given-names>S</given-names></string-name>, <string-name><surname>Brau</surname> <given-names>F</given-names></string-name>, <string-name><surname>Paquet</surname> <given-names>A</given-names></string-name>, <string-name><surname>Pe&#x2019;er</surname> <given-names>D</given-names></string-name>, <string-name><surname>Marquette</surname> <given-names>C-H</given-names></string-name>, <string-name><surname>Leroy</surname> <given-names>S</given-names></string-name>, <string-name><surname>Barbry</surname> <given-names>P.</given-names></string-name> <article-title>A Single-Cell Atlas of the Human Healthy Airways</article-title>. <source>Am J Respir Crit Care Med</source> <year>2020</year>; <volume>202</volume>: <fpage>1636</fpage>&#x2013;<lpage>1645</lpage>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="book"><string-name><surname>Tanga</surname> <given-names>V</given-names></string-name>, <string-name><surname>Leroy</surname> <given-names>S</given-names></string-name>, <string-name><surname>Fayada</surname> <given-names>J</given-names></string-name>, <string-name><surname>Hamila</surname> <given-names>M</given-names></string-name>, <string-name><surname>Allegra</surname> <given-names>M</given-names></string-name>, <string-name><surname>Messaoudi</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Bonnetaud</surname> <given-names>C</given-names></string-name>, <string-name><surname>Lespinet</surname> <given-names>V</given-names></string-name>, <string-name><surname>Bordone</surname> <given-names>O</given-names></string-name>, <string-name><surname>Washetine</surname> <given-names>K</given-names></string-name>, <string-name><surname>Griffonnet</surname> <given-names>J</given-names></string-name>, <string-name><surname>Maniel</surname> <given-names>C</given-names></string-name>, <string-name><surname>Philibert</surname> <given-names>L</given-names></string-name>, <string-name><surname>Selva</surname> <given-names>E</given-names></string-name>, <string-name><surname>Benzaquen</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ilie</surname> <given-names>M</given-names></string-name>, <string-name><surname>Long</surname> <given-names>E</given-names></string-name>, <string-name><surname>Lassalle</surname> <given-names>S</given-names></string-name>, <string-name><surname>Lant&#x00E9;ri</surname> <given-names>E</given-names></string-name>, <string-name><surname>Marquette</surname> <given-names>C-H</given-names></string-name>, <string-name><surname>Hofman</surname> <given-names>V</given-names></string-name>, <string-name><surname>Hofman</surname> <given-names>P.</given-names></string-name> <chapter-title>Establishment of a Collection of Blood-Derived Products from COVID-19 Patients for Translational Research: Experience of the LPCE Biobank (Nice, France</chapter-title>). <source>Biopreservation and Biobanking Mary Ann Liebert, Inc</source>., <publisher-name>publishers</publisher-name>; <year>2020</year>; <volume>18</volume>: <fpage>517</fpage>&#x2013;<lpage>524</lpage>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Sungnak</surname> <given-names>W</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>N</given-names></string-name>, <string-name><surname>B&#x00E9;cavin</surname> <given-names>C</given-names></string-name>, <string-name><surname>Berg</surname> <given-names>M</given-names></string-name>, <string-name><surname>Queen</surname> <given-names>R</given-names></string-name>, <string-name><surname>Litvinukova</surname> <given-names>M</given-names></string-name>, <string-name><surname>Talavera-L&#x00F3;pez</surname> <given-names>C</given-names></string-name>, <string-name><surname>Maatz</surname> <given-names>H</given-names></string-name>, <string-name><surname>Reichart</surname> <given-names>D</given-names></string-name>, <string-name><surname>Sampaziotis</surname> <given-names>F</given-names></string-name>, <string-name><surname>Worlock</surname> <given-names>KB</given-names></string-name>, <string-name><surname>Yoshida</surname> <given-names>M</given-names></string-name>, <string-name><surname>Barnes</surname> <given-names>JL</given-names></string-name>. <article-title>SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes</article-title>. <source>Nature Medicine Nature Publishing Group</source>; <year>2020</year>; <volume>26</volume>: <fpage>681</fpage>&#x2013;<lpage>687</lpage>.</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Ziegler</surname> <given-names>CGK</given-names></string-name>, <string-name><surname>Allon</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Nyquist</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Mbano</surname> <given-names>IM</given-names></string-name>, <string-name><surname>Miao</surname> <given-names>VN</given-names></string-name>, <string-name><surname>Tzouanas</surname> <given-names>CN</given-names></string-name>, <string-name><surname>Cao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Yousif</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Bals</surname> <given-names>J</given-names></string-name>, <string-name><surname>Hauser</surname> <given-names>BM</given-names></string-name>, <string-name><surname>Feldman</surname> <given-names>J</given-names></string-name>, <string-name><surname>Muus</surname> <given-names>C</given-names></string-name>, <string-name><surname>Wadsworth</surname> <given-names>MH</given-names></string-name>, <string-name><surname>Kazer</surname> <given-names>SW</given-names></string-name>, <string-name><surname>Hughes</surname> <given-names>TK</given-names></string-name>, <string-name><surname>Doran</surname> <given-names>B</given-names></string-name>, <string-name><surname>Gatter</surname> <given-names>GJ</given-names></string-name>, <string-name><surname>Vukovic</surname> <given-names>M</given-names></string-name>, <string-name><surname>Taliaferro</surname> <given-names>F</given-names></string-name>, <string-name><surname>Mead</surname> <given-names>BE</given-names></string-name>, <string-name><surname>Guo</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Gras</surname> <given-names>D</given-names></string-name>, <string-name><surname>Plaisant</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ansari</surname> <given-names>M</given-names></string-name>, <string-name><surname>Angelidis</surname> <given-names>I</given-names></string-name>, <string-name><surname>Adler</surname> <given-names>H</given-names></string-name>, <string-name><surname>Sucre</surname> <given-names>JMS</given-names></string-name>, <string-name><surname>Taylor</surname> <given-names>CJ</given-names></string-name>, <string-name><surname>Lin</surname> <given-names>B</given-names></string-name>, <etal>et al.</etal> <article-title>SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues</article-title>. <source>Cell</source> <year>2020</year>; <volume>181</volume>: <fpage>1016</fpage>-<lpage>1035</lpage>.e19.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="other"><string-name><surname>Hofman</surname> <given-names>P</given-names></string-name>, <string-name><surname>Boutros</surname> <given-names>J</given-names></string-name>, <string-name><surname>Benchetrit</surname> <given-names>D</given-names></string-name>, <string-name><surname>Benzaquen</surname> <given-names>J</given-names></string-name>, <string-name><surname>Leroy</surname> <given-names>S</given-names></string-name>, <string-name><surname>Tanga</surname> <given-names>V.</given-names></string-name> <article-title>A rapid near-patient RT-PCR test for suspected COVID-19. A study of the diagnostic accuracy</article-title>. <source>Annals of Translational Medicine 2021; ATM-21-690 accepted for publication on the 21st of march</source> <year>2021</year>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Lechien</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Chiesa-Estomba</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Place</surname> <given-names>S</given-names></string-name>, <string-name><surname>Van Laethem</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Cabaraux</surname> <given-names>P</given-names></string-name>, <string-name><surname>Mat</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Huet</surname> <given-names>K</given-names></string-name>, <string-name><surname>Plzak</surname> <given-names>J</given-names></string-name>, <string-name><surname>Horoi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hans</surname> <given-names>S</given-names></string-name>, <string-name><surname>Rosaria Barillari</surname> <given-names>M</given-names></string-name>, <string-name><surname>Cammaroto</surname> <given-names>G</given-names></string-name>, <string-name><surname>Fakhry</surname> <given-names>N</given-names></string-name>, <string-name><surname>Martiny</surname> <given-names>D</given-names></string-name>, <string-name><surname>Ayad</surname> <given-names>T</given-names></string-name>, <string-name><surname>Jouffe</surname> <given-names>L</given-names></string-name>, <string-name><surname>Hopkins</surname> <given-names>C</given-names></string-name>, <string-name><surname>Saussez</surname> <given-names>S</given-names></string-name>, <article-title>COVID-19 Task Force of YO-IFOS. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019</article-title>. <source>J Intern Med</source> <year>2020</year>; <volume>288</volume>: <fpage>335</fpage>&#x2013;<lpage>344</lpage>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="website"><collab>&#x00AB;?Contact tracing&#x00BB;?: arr&#x00EA;ter les cha&#x00EE;nes de transmission [Internet]</collab>. [cited 2021 Apr 13].Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ameli.fr/assure/covid-19/tester-alerter-proteger-comprendre-la-strategie-pour-stopper-lepidemie/contact-tracing-arreter-les-chaines-de-transmission">https://www.ameli.fr/assure/covid-19/tester-alerter-proteger-comprendre-la-strategie-pour-stopper-lepidemie/contact-tracing-arreter-les-chaines-de-transmission</ext-link>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="website"><collab>Avis du 25 septembre 2020 de la Soci&#x00E9;t&#x00E9; Fran&#x00E7;aise de Microbiologie (SFM) relatif &#x00E0; l&#x2019;interpr&#x00E9;tation de la valeur de Ct (estimation de la charge virale) obtenue en cas de RT-PCR SARS-CoV-2 positive sur les pr&#x00E9;l&#x00E8;vements cliniques r&#x00E9;alis&#x00E9;s &#x00E0; des fins diagnostiques ou de d&#x00E9;pistage</collab>. <source>Version 3</source> [Internet]. <year>2020</year> [cited 2021 Jan 22].Available from: <ext-link ext-link-type="uri" xlink:href="https://www.sfm-microbiologie.org/wp-content/uploads/2020/10/Avis-SFM-valeur-Ct-excre%CC%81tion-virale-_-Version-Finale-07102020-V3.pdf">https://www.sfm-microbiologie.org/wp-content/uploads/2020/10/Avis-SFM-valeur-Ct-excre%CC%81tion-virale-_-Version-Finale-07102020-V3.pdf</ext-link>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="website"><collab>CDC</collab>. <source>Healthcare Workers [Internet]. Centers for Disease Control and Prevention</source> <year>2020</year> [cited 2021 Apr 12].Available from: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html">https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html</ext-link>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="website"><collab>Diagnostic testing and screening for SARS-CoV-2 [Internet]</collab>. <source>European Centre for Disease Prevention and Control</source> [cited 2021 Apr 12].Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ecdc.europa.eu/en/covid-19/latest-evidence/diagnostic-testing">https://www.ecdc.europa.eu/en/covid-19/latest-evidence/diagnostic-testing</ext-link>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="other"><collab>Understanding cycle threshold (Ct) in SARS-CoV-2 RT-PCR</collab>. <source>[Internet] Public Health England</source>. Available from: <ext-link ext-link-type="uri" xlink:href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/926410/Understanding_Cycle_ThresholdCtin_SARS-CoV-2_RT-PCR_.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/926410/Understanding_Cycle_ThresholdCtin_SARS-CoV-2_RT-PCR_.pdf</ext-link>. : <volume>12</volume>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="other"><string-name><surname>Vandenberg</surname> <given-names>O</given-names></string-name>, <string-name><surname>Martiny</surname> <given-names>D</given-names></string-name>, <string-name><surname>Rochas</surname> <given-names>O</given-names></string-name>, <string-name><surname>van Belkum</surname> <given-names>A</given-names></string-name>, <string-name><surname>Kozlakidis</surname> <given-names>Z.</given-names></string-name> <article-title>Considerations for diagnostic COVID-19 tests</article-title>. <source>Nat Rev Microbiol</source> <year>2020</year>; : <fpage>1</fpage>&#x2013;<lpage>13</lpage>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Caulley</surname> <given-names>L</given-names></string-name>, <string-name><surname>Corsten</surname> <given-names>M</given-names></string-name>, <string-name><surname>Eapen</surname> <given-names>L</given-names></string-name>, <string-name><surname>Whelan</surname> <given-names>J</given-names></string-name>, <string-name><surname>Angel</surname> <given-names>JB</given-names></string-name>, <string-name><surname>Antonation</surname> <given-names>K</given-names></string-name>, <string-name><surname>Bastien</surname> <given-names>N</given-names></string-name>, <string-name><surname>Poliquin</surname> <given-names>G</given-names></string-name>, <string-name><surname>Johnson-Obaseki</surname> <given-names>S.</given-names></string-name> <article-title>Salivary Detection of COVID-19</article-title>. <source>Ann Intern Med American College of Physicians</source>; <year>2020</year>; <volume>174</volume>: <fpage>131</fpage>&#x2013;<lpage>133</lpage>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Barat</surname> <given-names>B</given-names></string-name>, <string-name><surname>Das</surname> <given-names>S</given-names></string-name>, <string-name><surname>Giorgi</surname> <given-names>VD</given-names></string-name>, <string-name><surname>Henderson</surname> <given-names>DK</given-names></string-name>, <string-name><surname>Kopka</surname> <given-names>S</given-names></string-name>, <string-name><surname>Lau</surname> <given-names>AF</given-names></string-name>, <string-name><surname>Miller</surname> <given-names>T</given-names></string-name>, <string-name><surname>Moriarty</surname> <given-names>T</given-names></string-name>, <string-name><surname>Palmore</surname> <given-names>TN</given-names></string-name>, <string-name><surname>Sawney</surname> <given-names>S</given-names></string-name>, <string-name><surname>Spalding</surname> <given-names>C</given-names></string-name>, <string-name><surname>Tanjutco</surname> <given-names>P</given-names></string-name>, <string-name><surname>Wortmann</surname> <given-names>G</given-names></string-name>, <string-name><surname>Zelazny</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Frank</surname> <given-names>KM</given-names></string-name>. <article-title>Pooled Saliva Specimens for SARS-CoV-2 Testing</article-title>. <source>Journal of Clinical Microbiology [Internet] American Society for Microbiology Journals</source>; <year>2021</year> [cited 2021 Apr 12]; <volume>59</volume> Available from: <ext-link ext-link-type="uri" xlink:href="https://jcm.asm.org/content/59/3/e02486-20">https://jcm.asm.org/content/59/3/e02486-20</ext-link>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Kandel</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zheng</surname> <given-names>J</given-names></string-name>, <string-name><surname>McCready</surname> <given-names>J</given-names></string-name>, <string-name><surname>Serbanescu</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Racher</surname> <given-names>H</given-names></string-name>, <string-name><surname>Desaulnier</surname> <given-names>M</given-names></string-name>, <string-name><surname>Powis</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Vojdani</surname> <given-names>K</given-names></string-name>, <string-name><surname>Finlay</surname> <given-names>L</given-names></string-name>, <string-name><surname>Sheldrake</surname> <given-names>E</given-names></string-name>, <string-name><surname>Vermeiren</surname> <given-names>C</given-names></string-name>, <string-name><surname>Katz</surname> <given-names>K</given-names></string-name>, <string-name><surname>McGeer</surname> <given-names>A</given-names></string-name>, <string-name><surname>Kozak</surname> <given-names>R</given-names></string-name>, <string-name><surname>Goneau</surname> <given-names>LW</given-names></string-name>. <article-title>Detection of SARS-CoV-2 from Saliva as Compared to Nasopharyngeal Swabs in Outpatients</article-title>. <source>Viruses Multidisciplinary Digital Publishing Institute</source>; <year>2020</year>; <volume>12</volume>: <fpage>1314</fpage>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Senok</surname> <given-names>A</given-names></string-name>, <string-name><surname>Alsuwaidi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Atrah</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ayedi</surname> <given-names>OA</given-names></string-name>, <string-name><surname>Zahid</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Han</surname> <given-names>A</given-names></string-name>, <string-name><surname>Marzooqi</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Heialy</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Altrabulsi</surname> <given-names>B</given-names></string-name>, <string-name><surname>AbdelWareth</surname> <given-names>L</given-names></string-name>, <string-name><surname>Idaghdour</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ali</surname> <given-names>R</given-names></string-name>, <string-name><surname>Loney</surname> <given-names>T</given-names></string-name>, <string-name><surname>Alsheikh-Ali</surname> <given-names>A.</given-names></string-name> <article-title>&#x003C;p&#x003E;Saliva as an Alternative Specimen for Molecular COVID-19 Testing in Community Settings and Population-Based Screening&#x003C;/p&#x003E;</article-title>. <source>IDR Dove Press</source>; <year>2020</year>; <volume>13</volume>: <fpage>3393</fpage>&#x2013;<lpage>3399</lpage>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Vogels</surname> <given-names>CBF</given-names></string-name>, <string-name><surname>Watkins</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Harden</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Brackney</surname> <given-names>DE</given-names></string-name>, <string-name><surname>Shafer</surname> <given-names>J</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Caraballo</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kalinich</surname> <given-names>CC</given-names></string-name>, <string-name><surname>Ott</surname> <given-names>IM</given-names></string-name>, <string-name><surname>Fauver</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Kudo</surname> <given-names>E</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>P</given-names></string-name>, <string-name><surname>Venkataraman</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tokuyama</surname> <given-names>M</given-names></string-name>, <string-name><surname>Moore</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Muenker</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Casanovas-Massana</surname> <given-names>A</given-names></string-name>, <string-name><surname>Fournier</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bermejo</surname> <given-names>S</given-names></string-name>, <string-name><surname>Campbell</surname> <given-names>M</given-names></string-name>, <string-name><surname>Datta</surname> <given-names>R</given-names></string-name>, <string-name><surname>Nelson</surname> <given-names>A</given-names></string-name>, <string-name><surname>Anastasio</surname> <given-names>K</given-names></string-name>, <string-name><surname>Askenase</surname> <given-names>MH</given-names></string-name>, <string-name><surname>Batsu</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bickerton</surname> <given-names>S</given-names></string-name>, <string-name><surname>Brower</surname> <given-names>K</given-names></string-name>, <string-name><surname>Bucklin</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Cahill</surname> <given-names>S</given-names></string-name>, <string-name><surname>Cao</surname> <given-names>Y</given-names></string-name>, <etal>et al.</etal> <article-title>SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity</article-title>. <source>Med</source> <year>2021</year>; <volume>2</volume>: <fpage>263</fpage>&#x2013;<lpage>280</lpage>.e6.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="website"><string-name><surname>Yokota</surname> <given-names>I</given-names></string-name>, <string-name><surname>Shane</surname> <given-names>PY</given-names></string-name>, <string-name><surname>Okada</surname> <given-names>K</given-names></string-name>, <string-name><surname>Unoki</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Inao</surname> <given-names>T</given-names></string-name>, <string-name><surname>Sakamaki</surname> <given-names>K</given-names></string-name>, <string-name><surname>Iwasaki</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hayasaka</surname> <given-names>K</given-names></string-name>, <string-name><surname>Sugita</surname> <given-names>J</given-names></string-name>, <string-name><surname>Nishida</surname> <given-names>M</given-names></string-name>, <string-name><surname>Fujisawa</surname> <given-names>S</given-names></string-name>, <string-name><surname>Teshima</surname> <given-names>T.</given-names></string-name> <article-title>Mass screening of asymptomatic persons for SARS-CoV-2 using saliva</article-title>. <source>Clinical Infectious Diseases [Internet]</source> <year>2020</year> [cited 2021 Apr 12]; Available from: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/cid/ciaa1388">https://doi.org/10.1093/cid/ciaa1388</ext-link>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Vlek</surname> <given-names>ALM</given-names></string-name>, <string-name><surname>Wesselius</surname> <given-names>TS</given-names></string-name>, <string-name><surname>Achterberg</surname> <given-names>R</given-names></string-name>, <string-name><surname>Thijsen</surname> <given-names>SFT</given-names></string-name>. <article-title>Combined throat/nasal swab sampling for SARS-CoV-2 is equivalent to nasopharyngeal sampling</article-title>. <source>Eur J Clin Microbiol Infect Dis</source> <year>2021</year>; <volume>40</volume>: <fpage>193</fpage>&#x2013;<lpage>195</lpage>.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Tan</surname> <given-names>L</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>W</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Cheng</surname> <given-names>L</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>Z.</given-names></string-name> <article-title>Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously</article-title>. <source>International Journal of Infectious Diseases</source> <year>2020</year>; <volume>94</volume>: <fpage>107</fpage>&#x2013;<lpage>109</lpage>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="website"><string-name><surname>Patel</surname> <given-names>MR</given-names></string-name>, <string-name><surname>Carroll</surname> <given-names>D</given-names></string-name>, <string-name><surname>Ussery</surname> <given-names>E</given-names></string-name>, <string-name><surname>Whitham</surname> <given-names>H</given-names></string-name>, <string-name><surname>Elkins</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Noble-Wang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Rasheed</surname> <given-names>JK</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Lindstrom</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bowen</surname> <given-names>V</given-names></string-name>, <string-name><surname>Waller</surname> <given-names>J</given-names></string-name>, <string-name><surname>Armstrong</surname> <given-names>G</given-names></string-name>, <string-name><surname>Gerber</surname> <given-names>S</given-names></string-name>, <string-name><surname>Brooks</surname> <given-names>JT</given-names></string-name>. <article-title>Performance of Oropharyngeal Swab Testing Compared With Nasopharyngeal Swab Testing for Diagnosis of Coronavirus Disease 2019&#x2014;United States, January 2020&#x2013;February 2020</article-title>. <source>Clin Infect Dis [Internet]</source> <year>2020</year> [cited 2021 Feb 8]; Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337670/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337670/</ext-link>.</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Muus</surname> <given-names>C</given-names></string-name>, <string-name><surname>Luecken</surname> <given-names>MD</given-names></string-name>, <string-name><surname>Eraslan</surname> <given-names>G</given-names></string-name>, <string-name><surname>Sikkema</surname> <given-names>L</given-names></string-name>, <string-name><surname>Waghray</surname> <given-names>A</given-names></string-name>, <string-name><surname>Heimberg</surname> <given-names>G</given-names></string-name>, <string-name><surname>Kobayashi</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Vaishnav</surname> <given-names>ED</given-names></string-name>, <string-name><surname>Subramanian</surname> <given-names>A</given-names></string-name>, <string-name><surname>Smillie</surname> <given-names>C</given-names></string-name>, <string-name><surname>Jagadeesh</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Duong</surname> <given-names>ET</given-names></string-name>, <string-name><surname>Fiskin</surname> <given-names>E</given-names></string-name>, <string-name><surname>Triglia</surname> <given-names>ET</given-names></string-name>, <string-name><surname>Ansari</surname> <given-names>M</given-names></string-name>, <string-name><surname>Cai</surname> <given-names>P</given-names></string-name>, <string-name><surname>Lin</surname> <given-names>B</given-names></string-name>, <string-name><surname>Buchanan</surname> <given-names>J</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Shu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Haber</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Chung</surname> <given-names>H</given-names></string-name>, <string-name><surname>Montoro</surname> <given-names>DT</given-names></string-name>, <string-name><surname>Adams</surname> <given-names>T</given-names></string-name>, <string-name><surname>Aliee</surname> <given-names>H</given-names></string-name>, <string-name><surname>Allon</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Andrusivova</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Angelidis</surname> <given-names>I</given-names></string-name>, <string-name><surname>Ashenberg</surname> <given-names>O</given-names></string-name>, <string-name><surname>Bassler</surname> <given-names>K</given-names></string-name>, <etal>et al.</etal> <article-title>Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics</article-title>. <source>Nature Medicine Nature Publishing Group</source>; <year>2021</year>; <volume>27</volume>: <fpage>546</fpage>&#x2013;<lpage>559</lpage>.</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="other"><string-name><surname>L&#x2019;Helgouach</surname> <given-names>N</given-names></string-name>, <string-name><surname>Champigneux</surname> <given-names>P</given-names></string-name>, <string-name><surname>Schneider</surname> <given-names>FS</given-names></string-name>, <string-name><surname>Molina</surname> <given-names>L</given-names></string-name>, <string-name><surname>Espeut</surname> <given-names>J</given-names></string-name>, <string-name><surname>Alali</surname> <given-names>M</given-names></string-name>, <string-name><surname>Baptiste</surname> <given-names>J</given-names></string-name>, <string-name><surname>Cardeur</surname> <given-names>L</given-names></string-name>, <string-name><surname>Dubuc</surname> <given-names>B</given-names></string-name>, <string-name><surname>Foulongne</surname> <given-names>V</given-names></string-name>, <string-name><surname>Galtier</surname> <given-names>F</given-names></string-name>, <string-name><surname>Makinson</surname> <given-names>A</given-names></string-name>, <string-name><surname>Marin</surname> <given-names>G</given-names></string-name>, <string-name><surname>Picot</surname> <given-names>M-C</given-names></string-name>, <string-name><surname>Prieux-Lejeune</surname> <given-names>A</given-names></string-name>, <string-name><surname>Quenot</surname> <given-names>M</given-names></string-name>, <string-name><surname>Robles</surname> <given-names>FC</given-names></string-name>, <string-name><surname>Salvetat</surname> <given-names>N</given-names></string-name>, <string-name><surname>Vetter</surname> <given-names>D</given-names></string-name>, <string-name><surname>Reynes</surname> <given-names>J</given-names></string-name>, <string-name><surname>Molina</surname> <given-names>F.</given-names></string-name> <article-title>EasyCOV?: LAMP based rapid detection of SARS-CoV-2 in saliva</article-title>. <source>medRxiv Cold Spring Harbor Laboratory Press</source>; <year>2020</year>; : 2020.05.30.20117291.</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Lai</surname> <given-names>CKC</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Lui</surname> <given-names>G</given-names></string-name>, <string-name><surname>Ling</surname> <given-names>L</given-names></string-name>, <string-name><surname>Li</surname> <given-names>T</given-names></string-name>, <string-name><surname>Wong</surname> <given-names>MCS</given-names></string-name>, <string-name><surname>Ng</surname> <given-names>RWY</given-names></string-name>, <string-name><surname>Tso</surname> <given-names>EYK</given-names></string-name>, <string-name><surname>Ho</surname> <given-names>T</given-names></string-name>, <string-name><surname>Fung</surname> <given-names>KSC</given-names></string-name>, <string-name><surname>Ng</surname> <given-names>ST</given-names></string-name>, <string-name><surname>Wong</surname> <given-names>BKC</given-names></string-name>, <string-name><surname>Boon</surname> <given-names>SS</given-names></string-name>, <string-name><surname>Hui</surname> <given-names>DSC</given-names></string-name>, <string-name><surname>Chan</surname> <given-names>PKS.</given-names></string-name> <article-title>Prospective Study Comparing Deep Throat Saliva With Other Respiratory Tract Specimens in the Diagnosis of Novel Coronavirus Disease 2019</article-title>. <source>The Journal of Infectious Diseases</source> <year>2020</year>; <volume>222</volume>: <fpage>1612</fpage>&#x2013;<lpage>1619</lpage>.</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname> <given-names>JH-K</given-names></string-name>, <string-name><surname>Yip</surname> <given-names>CC-Y</given-names></string-name>, <string-name><surname>Poon</surname> <given-names>RW-S</given-names></string-name>, <string-name><surname>Chan</surname> <given-names>K-H</given-names></string-name>, <string-name><surname>Cheng</surname> <given-names>VC-C</given-names></string-name>, <string-name><surname>Hung</surname> <given-names>IF-N</given-names></string-name>, <string-name><surname>Chan</surname> <given-names>JF-W</given-names></string-name>, <string-name><surname>Yuen</surname> <given-names>K-Y</given-names></string-name>, <article-title>To KK-W. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2</article-title>. <source>Emerging Microbes &#x0026; Infections</source> <year>2020</year>; <volume>9</volume>: <fpage>1356</fpage>&#x2013;<lpage>1359</lpage>.</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="other"><string-name><surname>Watkins</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Fenichel</surname> <given-names>EP</given-names></string-name>, <string-name><surname>Weinberger</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Vogels</surname> <given-names>CBF</given-names></string-name>, <string-name><surname>Brackney</surname> <given-names>DE</given-names></string-name>, <string-name><surname>Casanovas-Massana</surname> <given-names>A</given-names></string-name>, <string-name><surname>Campbell</surname> <given-names>M</given-names></string-name>, <string-name><surname>Fournier</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bermejo</surname> <given-names>S</given-names></string-name>, <string-name><surname>Datta</surname> <given-names>R</given-names></string-name>, <string-name><surname>Dela Cruz</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Farhadian</surname> <given-names>SF</given-names></string-name>, <string-name><surname>Iwasaki</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ko</surname> <given-names>AI</given-names></string-name>, <string-name><surname>Grubaugh</surname> <given-names>ND</given-names></string-name>, <string-name><surname>Wyllie</surname> <given-names>AL</given-names></string-name>, <article-title>Yale IMPACT Research Team2. Increased SARS-CoV-2 Testing Capacity with Pooled Saliva Samples</article-title>. <source>Emerg Infect Dis</source> <year>2021</year>; <fpage>27</fpage>.</mixed-citation></ref>
</ref-list>
<app-group>
<app id="app1">
<label>1 APPENDIX</label>
<title>PROCEDURES</title>
<sec id="s6">
<title>Detection of SARS-CoV-2 RNA with naso-pharyngeal swab specimens</title>
<p>During the first study period (September 21, 2020 to January 6, 2021; symptomatic patients), naso-pharyngeal (NP) swab specimens were analyzed by RT-PCR using the ORF1ab and N genes Da An Gene DA0992-Detection Kit for 2019-nCoV (Da An Gene Co., Ltd. Sun Yat-sen University, Guangzhou, Guangdong, China). NP swabs were eluted into a vial containing 400 &#x00B5;l of viral RNA extraction buffer (RNA/DNA purification kit, Da An Gene, ref DA0940); and 5 &#x03BC;l was then processed on an AGS 4800 Thermocycler (Hangzhou, Zhejiang, China). According to the guidelines of the French Society for Microbiology [reference 30 Avis du 25 septembre 2020 de la Soci&#x00E9;t&#x00E9; Fran&#x00E7;aise de Microbiologie (SFM) relatif &#x00E0; l&#x2019;interpr&#x00E9;tation de la valeur de Ct] the result was considered as positive when the Ct (cycle threshold) value for the N and/or Orf1b genes was equal or less than 36.</p>
<p>During the second study period (February 6 to March 6, 2021; close contacts) NP samples were analyses with the Aptima<sup>&#x00AE;</sup> SARS-CoV-2 assay (Hologic, Inc. 10210 Genetic Center Drive San Diego, CA 92121 USA), which combines Transcription Mediated Amplification (TMA), and Dual Kinetic Assay (DKA) that amplifies and detects two conserved regions of the ORF1ab gene. NP swabs were eluted into a vial containing 710 &#x00B5;l of medium (Hologic Specimen Lysis Tubes, ref PDD-06554) before being tested on the Panther system. Assay results were determined with a cut-off based on the total Relative Light Units (RLU). According to the guidelines of the French Society for Microbiology the results were considered as positive when the RLU was above 850.</p>
</sec>
<sec id="s7">
<title><italic>Detection of SARS-CoV-2 RNA with oral sponge (OS) specimens at</italic> the Synlab Barla laboratory</title>
<p>25 &#x03BC;l of the OS eluates transferred fresh from the Nice COVID-19 biobank were put into a vial containing 400 &#x00B5;l of viral RNA extraction buffer (RNA/DNA purification kit, Da An Gene, ref DA0940); and 5 &#x03BC;l was then processed on an AGS 4800 Thermocycler (Hangzhou, Zhejiang, China).</p>
</sec>
</app>
</app-group>
</back>
</article>